This inventor holds 1 USPTO granted patent. Top assignee: Merck Patent Gesellschaft MIT Beschrankter Haftung. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: The Innovations of Keith H Ansell
Introduction
Keith H Ansell is a notable inventor based in Hatfield, GB. He has made significant contributions to the field of biotechnology, particularly in the development of anti-EGFR therapies. His work has implications for cancer treatment, showcasing the importance of innovation in medical science.
Latest Patents
Keith H Ansell holds a patent for "Anti-EGFR single-chain Fvs and anti-EGFR antibodies." This patent represents a crucial advancement in targeted therapies for cancer, highlighting his role in the ongoing fight against this disease. He has 1 patent to his name, reflecting his focused contributions to the field.
Career Highlights
Ansell is associated with Merck Patent Gesellschaft mit beschränkter Haftung, a leading company in the pharmaceutical industry. His work at Merck has allowed him to collaborate with other talented professionals and contribute to groundbreaking research in biotechnology.
Collaborations
Some of his notable coworkers include A Cathrine Kettleborough and Mary M Bendig. Their collective efforts in research and development have furthered the understanding and application of anti-EGFR therapies.
Conclusion
Keith H Ansell's innovative work in the field of biotechnology exemplifies the impact of dedicated inventors on medical advancements. His contributions continue to influence cancer treatment strategies and inspire future research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile